Key scenarios for separate supplementation include: Diagnosed deficiencies requiring high-dose supplementation
The combined effects of activating fibroblasts and endothelial cells are improved skin flexibility, improved wound healing, and decreases in fine lines and wrinkles
What I'm seeing in Q1 2026: - Exosome products flooding the market (90%+ won't survive FDA scrutiny) - Peptide therapeutics moving from "experimental" to mainstream adoption in aesthetic practices - PRP protocols becoming table stakes practices that don't offer them are losing patients - Compounding pharmacies scaling regenerative offerings (GLP-1 peptides longevity programs) - Telehealth platforms expanding beyond weight loss into tissue repair and athletic recovery The question isn't IF regenerative medicine becomes a multi-billion dollar category
Angiogenesis Studies: Angiogenic potential investigated through multiple assays: HUVEC tube formation (network complexity), endothelial migration (cells/field), aortic ring sprouting (sprout length/number), VEGF/VEGFR2 expression (qPCR, Western blot), CAM assay (vessel density)
Standard protocols use insulin syringes with 29 or 30 gauge needles, minimizing discomfort and allowing self-administration
Some types of edible algae and fermented foods may also contain small amounts, but they arent reliable sources
